Government Support Injecting Growth In Russian Pharma Industry Says New Report

“Russian Pharma Sector Analysis (2007)” provides a keen insight into the Russian pharmaceutical market by systematically evaluating the emerging trends impacting the market and thus predicts its future performance. It addresses the key opportunities and challenges, driving factors, and impact of government policies on the pharmaceutical market. End Quote

(1888PressRelease) January 05, 2008 - Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report showing that increasing ageing population, rising health consciousness, medical insurance, strong government support and the rising sales volume of expensive drugs -are the key factors that will drive the Russian pharmaceutical market during 2007-2011. On the back of these factors, the Russian pharmaceutical industry is anticipated to increase at a CAGR of over 15% during 2007 to 2011.

“Russian Pharma Sector Analysis (2007)” (http://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/russian_pharma_sector_analysis_2007.html) reports that drugs for Cancer, HIV, and Cardiovascular ailments will provide the biggest opportunity area for the Russian pharmaceutical market in the future. Moreover, the diabetic population of the country is also increasing leading to heightened demand for insulin, which forms another prospective area.

According to the report, the pharmaceutical market in Russia started experiencing massive expansion globally in 2006, with both the commercial and state segments posting double-digit growth in the sales value, with a major boost coming from the drug reimbursement program of the government. It also evaluates the market segments of the industry that mainly consist of the state segment, commercial segment and the Para pharmaceutical segment which have experienced exceptional growth.

The research finds a unique trend in the Russian pharmaceutical market where the sales of the drugs declined in terms of volume but amplified in terms of value.

The report also specifies obstacles which might obstruct the growth of the Russian pharmaceutical market in future. These include huge percentage of counterfeit drugs, IPR protection regime and poor quality control standards. “Russian Pharma Sector Analysis (2007)” provides a keen insight into the Russian pharmaceutical market by systematically evaluating the emerging trends impacting the market and thus predicts its future performance. It addresses the key opportunities and challenges, driving factors, and impact of government policies on the pharmaceutical market.

This research report is a work of in-depth analysis of the Russian pharmaceutical industry, covering various market parameters like the size of pharma market, structure of the health care sector, demographics, and a comparative analysis of the market segments.

“Russian Pharma Sector Analysis (2007)” is available from Report Buyer. For more information go to: http://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/russian_pharma_sector_analysis_2007.html

Report Buyer product ID: RCS00216

About Report Buyer
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare. The website now carries over 40,000 business information products, including market reports, studies and books. Report Buyer is the intelligent way to buy market research making it an essential resource for executives and information buyers worldwide. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

###

Visit Report Buyer Website

space